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Available online 25 July 2013Abstract Objective Acetaminophen intoxication is a leading cause of acute liver failure. Liver transplantation for
acute liver failure is limited by the availability of donor organs. In this study, we aimed at identifying if the transplantation of
adipose tissue-mesenchymal stem cells (ASCs) may exert therapeutic effects on acetaminophen-induced liver injury.
Methods ASCs were isolated from human subcutaneous tissue and were transfected with a green fluorescent protein (GFP).
Sprague–Dawley rats were administrated 300 mg/kg of acetaminophen intraperitoneally and were transplanted with ASCs
or vehicle. After 24 h from acetaminophen administration, rats were sacrificed. Hepatic levels of isoprostanes, 8-hydroxyguanosine
(8-OHG), nitrites/nitrates and reduced glutathione (GSH) were determined as markers of oxidative stress; JNK phosphorylation
and hepatic levels of inflammatory cytokines and regeneration factors were also assessed.
Results Transplantation of ASCs decreased AST, ALT and prothrombin time to the levels observed in control rats. Transplanted
animals had normal plasma ammonia and did not display clinical encephalopathy. Liver sections of intoxicated rats treated
with vehicle showed lobular necrosis and diffuse vacuolar degeneration; in rats transplanted with ASCs liver injury was almost
absent. Transplantation of ASCs decreased liver isoprostanes, 8-OHG and nitrite–nitrates to the levels of control rats,
while preserving GSH. Consistently, hepatic levels of TNF-α, MCP-1, IL-1β, ICAM-1 and phospho-JNK were markedly increased
in rats treated with vehicle and were restored to the levels of controls in animals transplanted with ASCs. Furthermore,
ASC transplantation increased liver expression of cyclin D1 and PCNA, two established hepatocyte regeneration factors, whereas
ASCs were not able to metabolize acetaminophen in vitro.
Conclusion In this study, we demonstrated that ASC transplantation is effective in treating acetaminophen liver injury by
enhancing hepatocyte regeneration and inhibiting liver stress and inflammatory signaling.
© 2013 Elsevier B.V. All rights reserved.Abbreviations: ALF, acute liver failure; GSH, reduced glutathione; OLT, orthotopic liver transplantation; MSCs, mesenchymal stem cells;
ASCs, adipose tissue mesenchymal stem cells; GFP, green fluorescent protein; 8-OHG, 8-hydroxyguanosine; BM-MSCs, bone marrow
mesenchymal stem cells; PCNA, proliferating cell nuclear antigen.
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Acute liver failure (ALF) is a life-threatening condition in
which an acute liver injury can lead to coagulopathy, brain
edema and in many cases to multiorgan failure; a variety of
etiologies including drugs, viral infections, alcohol, meta-
bolic, autoimmune or genetic disorders may cause acute
hepatic dysfunction leading to liver failure (Lee and Stravitz,
2011). The main cause of ALF in industrialized countries is
acetaminophen intoxication; although acetaminophen is a
safe and widely used analgesic drug, its overdose can lead to
ALF and the mortality for acetaminophen intoxication is
currently impressive (Lee and Stravitz, 2011).
A number of studies in human and rodents suggest that
oxidative stress plays a key role in the pathogenesis of
acetaminophen-induced liver injury (Jaeschke et al., 2012).
Oxidative stress is the consequence of the acute depletion of
reduced glutathione (GSH) that occurs early, after 1.5 to 2 h
from acetaminophen overdose, and it is caused by the
generation of N-acetyl-p-benzoquinone imine (NAPQI), the
toxic metabolite of acetaminophen (Jaeschke et al., 2012).
This early event impairs the antioxidant defense of the liver
against reactive oxygen species and reactive nitrogen
species; the increase of radical species triggers lipid and
protein peroxidation, and DNA oxidative damage with
consequent death of hepatocytes (Jaeschke et al., 2012).
The treatment of acetaminophen intoxication is based
on the use of N-acetyl-cysteine (Lee and Stravitz, 2011).
However, in a number of patients with acetaminophen-
induced acute liver injury, pharmacological treatment fails
and patients need to undergo orthotopic liver transplanta-
tion (OLT) (Lee and Stravitz, 2011). Nonetheless, the
shortage of donor organs for OLT makes the need of
finding alternative therapeutic options. Recently, the
transplantation of mesenchymal stem cells (MSCs) has been
identified as a therapeutic tool in different types of
experimental liver injuries (Sato et al., 2005; Kuo et al.,
2008). MSCs are adherent, fibroblast-like, pluripotent and
non-hematopoietic progenitor cells, which reside in many
tissues and organs investigated so far including the bone
marrow (Pittenger et al., 1999), umbilical cord (Bieback et
al., 2004), placenta (In 't Anker et al., 2004), amniotic fluid
(De Coppi et al., 2007) and subcutaneous adipose tissue (Zuk
et al., 2001). Adipose tissue mesenchymal stem cells (ASCs)
are abundant in subcutaneous adipose tissue and can be
easily obtained by lipoaspiration, thus representing a fast
source of MSCs in patients with critical acute diseases. The
transplantation of ASCs has demonstrated therapeutic
efficacy in CCl4 (Banas et al., 2008), concanavalin A (Kubo
et al., 2012) and ischemia–reperfusion (Sun et al., 2012)
liver injuries. In this study, we aimed at identifying if the
transplantation of ASCs may exert therapeutic effects in rats
with acetaminophen-induced liver injury and the underlying
molecular events.Materials and methods
ASC isolation, culture and transfection
Subcutaneous adipose tissue was obtained from a 23-year-old
man with no significant medical history undergoing umbilicalhernioplasty. Written consent was obtained. The choice of a
single young and healthy man as source of ASCs was in order to
eliminate any bias related to the use of cells from different
individuals, which can display different functional activity,
and to exclude any situation of disease that could have affect
the proliferative properties of ASCs. Adipose tissue was
minced with scissors and scalpels into less than 3-mm pieces
and isolation of ASCs proceeded as previously described (Banas
et al., 2007). Briefly, after gentle shaking with equal volume
of PBS, the mixture separated into two phases. The upper
phase (containing stem cells, adipocytes and blood) after
washing with PBS was enzymatically dissociated with 0.075%
collagenase (type I)/PBS for 1 h at 37 °C with gentle shaking.
The dissociated tissue was thenmixedwith an equal volume of
DMEM (GIBCO-BRL, Japan) supplemented with 10% FBS and
incubated 10 min at room temperature. The solution then was
separated into two phases. The lower phase was centrifuged
at 1500 rpm for 5 min at 20 °C. The cellular pellet was
resuspended in 160 mM NH4Cl to eliminate erythrocytes and
passed through a 40 μmmesh filter into a new tube. The cells
were resuspended in an equal volume of DMEM/10% FBS and
then centrifuged. Isolation resulted in obtaining 7.7 × 106 of
adherent cells for a primary culture from 5 g of adipose tissue
(approximately; 1.0 × 105 to 4.6 × 106/1 g) after 7 to 10 days
of culture. The cells were suspended in a DMEM/10% FBS
plated in concentration 1–5 × 106 cells/75 cm2. The cells
with 70%–80% confluence were harvested with 0.25% trypsin–
EDTA and then either repleted at 1.0 × 105 cells/60-mm dish.
The phenotype of ASCs was evaluated by flow cytometry
analysis (FC500 Beckman Coulter). Flow cytometry revealed
that the cells isolated from the subcutaneous adipose tissue
expressed stromal-associatedmarkers CD90 and CD105 but did
not express the hematopoietic markers CD34 and CD45 (Suppl.
Fig. 1). In an in vitro experiment to establish if ASCs
metabolize acetaminophen, cells were treated with 2 mM
acetaminophen; NAPQI concentration was measured in the
cell medium after 2, 8 and 24 h. For the in vivo experiment,
before transplantation cells were transfected with a
baculovirus-mediated transfection system for green fluores-
cent protein (GFP) (Invitrogen, US).Animals and treatments
All procedures fulfilled the Italian Guidelines for the Use and
Care of Laboratory Animals. Sprague–Dawley female rats
were purchased from Charles River Lab (Calco, Italy).
Animals were maintained in a light- and temperature-
controlled facility and fed with a standard chow and water
ad libitum. After an overnight fast, twelve rats weighing
about 200 g were administrated a 300 mg/kg body weight
dose of acetaminophen (Sigma, Italy) dissolved in PBS. After
2 h from acetaminophen administration, six rats received
the infusion via the caudal vein of 200,000 cells suspended in
1 mL of saline; six rats were administrated only saline. Four
rats were administrated only the vehicles, PBS and saline,
and served as healthy control. ASCs were administrated 2 h
after acetaminophen administration because this is the time
occurring for the formation of NAPQI, and this early time
point is widely used in animal studies evaluating the efficacy
of a treatment for acetaminophen intoxication (Saito et al.,
2010). After 24 h from acetaminophen administration, rats
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were harvested for further analysis.
Biochemical analyses
Plasma levels of ALT, AST, ammonia and prothrombin time
were determined on blood samples using a Cobas
Multi-analyzer (Roche Diagnostics, UK). Isoprostanes and
8-hydroxyguanosine (8-OHG) were determined by enzyme-
linked immunosorbent assay (ELISA) test (Cayman, Ann Arbor,
Michigan); GSH was assessed by a GSH assay (Cayman).
Nitrite/nitrates were measured colorimetrically using Griess
reagent (Merck KGaA, Darmstadt, Germany), following the
manufacturer's instructions. Whole liver homogenates were
processed for Western blot analysis and protein levels were
visualized by immunoblotting with antibodies against
total-JNK and phospho-JNK (Chemicon, Temecula, CA), cyclin
D1, proliferating cell nuclear antigen and β-actin (all from
Santa Cruz, TX).
High performance liquid chromatography
NAPQI concentrations were determined using the Agilent
6410 Triple Quadruple Mass Spectrometer (Triple Quad MS)
with an Electrospray Ionization (ESI) source (Agilent Tech-
nologies, USA). The chromatographic separation was
achieved on a Gemini-NX C18 (50 mm × 2.0 mm, 3 μm)
column. All data were acquired employing Agilent 6410
Quantitative Analysis version B.01.03 analyst data process-
ing software. In preliminary in vitro experiments, in the
absence of cells, we noticed that the recovery of acetamin-
ophen from the FBS-containing medium is substantially
reduced when compared to the nominal amount (the amount
added to the solution). This may be due to binding to the
plastic ware and FBS proteins. Thus, we measured only
NAPQI to establish if ASCs metabolize acetaminophen. NAPQI
was analyzed in cell medium, which was diluted in ultrapure
water and an aliquot of 5 μL was injected into the HPLC
column. Standard stock solutions of NAPQI was dissolved in
water to obtain an exact final concentration of 20 μg/mL of
NAPQI, and stored at +4 °C. Target calibration range was
0.101–20 μg/mL (LOD was 101.51 ng/mL). The flow rate
was set at 0.2 mL/min. An isocratic of mobile phase in 5 min
for assay (U.P. water, with 0.1% HCOOH and CAN, with 0.1%
HCOOH, 90/10, v/v solution). NAPQI was ionized under
positive ionization conditions. The predominant peak in the
primary ESI spectra of NAPQI corresponds to the [M − H −
H2O]+ ion at m/z 168, both product ion for NAPQI at m/z 126.
Chromatograms were integrated and the calibration curves
were plotted as the peak area of NAPQI (Suppl. Fig. 2). The
coefficients of variation were less than 15%; the determina-
tion coefficient (r2) was 0.999.
Morphological analyses
Liver samples were fixed in 10% buffered formalin and
embedded in paraffin using standard techniques. Histological
damage was evaluated by using hematoxylin–eosin staining.
Indirect immunofluorescence for the identification of GFP+
cells was performed on frozen liver samples. Monoclonal
antibodies for human CK-18 and vimentin (both from
DakoCytomation, Italy) were used on paraffin-embeddedsections, following the manufacturer's instructions. All anti-
bodies did not cross-react with rat proteins, as evidenced in
previous experiments.
RNA extraction and real time PCR
Total RNA was extracted by homogenizing snap frozen liver
samples in TRIzol reagent (Invitrogen, Milan, Italy). Quantita-
tive real-time PCR was performed in 7900HT Fast Real-Time
PCR System Applied Biosystems (Applied Biosystems, Foster
City, CA), using the EXPRESS SYBR GreenER™ qPCR SuperMix
with Premixed ROX (Invitrogen). The following primer se-
quences were used: TNF-α fw 5′-CGAGTGACAAGCCTGTAGC-3′
rev 5′-GGTGTGGGTGAGGAGCACAT-3′; ICAM-1 fw 5′-CCTTCCT
CACCGTGTACTGG-3′ rev 5′-AGCGTAGGGTAAGGTTCTTGC-3′;
MCP-1 fw 5′-CATAGCAGCCACCTTCATTCC-3′ rev 5′-TCTGCACT
GAGATCTTCCTATTGG-3′; IL-1β fw 5′-AAGCTGATGGCCCTAAA
CAG-3′ rev 5′-AGGTGCATCGTGCACATAAG-3′; GAPDH fw 5′-GGT
GGTCTCCTCTGACTTCAACA-3′ rev 5′-GTTGCTGTAGCCAAATTC
GTTGT-3′; reactions were performed in a 20 μL mixture
containing cDNA, specific primers of each gene and the SYBR
GreenER™ qPCR SuperMix. The specific PCR products were
detected by the fluorescence of SYBR Green, the double
stranded DNA binding dye. The relative mRNA expression level
was calculated by the threshold cycle (Ct) value of each PCR
product and normalized with that of GAPDH by using compar-
ative 2–ΔΔCt method.
Statistical analysis
Statistics were aided by GraphPad Prism. All results were
expressed as mean ± standard deviation. Unpaired t test and
one-way ANOVA with Bonferroni post-hoc analysis were used
when appropriate. P values less than 0.05 were considered
significant.
Results
Effects of ASC transplantation on plasma markers of
liver injury
Rats intoxicated with acetaminophen and treated with
vehicle displayed a marked increase in plasma levels of ALT
and AST as compared with control animals (Figs. 1A, B);
interestingly, rats transplanted with ASCs displayed normal
plasma AST and ALT activities (Figs. 1A, B). Consistently,
prothrombin time, as measured by INR, was elevated in rats
treated with vehicle and was restored to the levels observed
in the control group in rats transplanted with ASCs (Fig. 1C).
Furthermore, animals treated with vehicle had clinical
evidence of encephalopathy and a mild increase in plasma
ammonia (Fig. 1D); by contrast, rats transplanted with ASCs
did not display encephalopathy and had normal levels of
plasma ammonia (Fig. 1D).
Effects of ASC transplantation on liver histology
Rats intoxicatedwith acetaminophen and treatedwith vehicle
displayed diffused vacuolar degeneration, due to mitochon-
drial damage, and necroinflammatory foci in the lobular area
(Fig. 2B). Lobular necrosis was absent in rats transplantedwith
Figure 1 Effects of ASC transplantation on plasma markers of liver injury. (A, B) Rats intoxicated with acetaminophen and treated
with vehicle displayed a marked increase in plasma levels of ALT and AST as compared with control animals; rats transplanted with
ASCs displayed normal plasma ALT and AST activities. (C,D) INR and plasma ammonia were elevated in rats with acetaminophen
overdose treated with vehicle and were restored to the levels observed in the control group in rats transplanted with ASCs. *P b 0.05
vs vehicle; **P b 0.05 vs APAP + vehicle.
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observed. Moreover, mitotic hepatocytes were observed in
liver sections of rats transplanted with ASCs (Fig. 2C), whereas
these were not present in control rats (Fig. 2A). Immunoflu-
orescence for GFP revealed the presence of ASCs in liver
sections of transplanted rats (Fig. 2D). In most sections, ASCs
presented a shaped fibroblast-like morphology (Fig. 2D); only,
in few sections, ASCs appeared with a round epithelial-like
morphology (Fig. 2D). Immunohistochemistry with a monoclo-
nal antibody against human vimentin, a typical mesenchymal
marker, was positive in most liver sections from transplanted
rats (Fig. 2E), whereas immunohistochemistry for human
CK-18 revealed the presence of only rare ASCs undergoing
differentiation (Fig. 2F), suggesting that ASCs exert a
therapeutic effect by maintaining their mesenchymal
phenotype.Effects of ASCs on markers of liver oxidative stress,
inflammation and regeneration
Rats intoxicated with acetaminophen displayed a three-fold
increase in hepatic levels of isoprostanes as compared with
control healthy animals (Fig. 3A), indicating significant lipid
peroxidation. Interestingly, rats transplanted with ASCs hadisoprostane levels similar to the control group (Fig. 3A).
Similarly, rats with acetaminophen intoxication presented a
marked increase in liver 8-OHG as compared with control
healthy animals (Fig. 3B); rats transplanted with ASCs had
8-OHG levels not different from the control group (Fig. 3B),
indicating DNA protection exerted by ASCs. Consistently with
isoprostanes and 8-OHG values, animals with acetaminophen
overdose presented increased levels of hepatic nitrite/
nitrates, a marker of nitrosative stress, as compared to
control rats (Fig. 3C). Strikingly, in animals transplanted with
ASCs, nitrite/nitrates were comparable to the control group
(Fig. 3D). Furthermore, acetaminophen intoxication leads to a
marked increase of phospho-JNK expression whereas the
levels of total JNK were not significantly modified. In rats
transplanted with ASCs, p-JNK expression was restored to the
levels observed in the control group (Fig. 3E). Consistently, in
the liver, gene expression of inflammatory cytokines was
induced by acetaminophen intoxication (Figs. 4A–D). In
agreement with histological findings, ASC transplantation
decreased the gene expression of TNF-α, MCP-1, IL-1β and
ICAM-1 to the levels observed in healthy controls (Figs. 4A–D).
Furthermore, animals transplanted with ASCs displayed
increased expression of cyclin D1 and PCNA (Figs. 5A–C),
indicating that these cells exert hepatoprotective effects by
promoting liver regeneration. To confirm that ASCs exerted
Figure 2 Effects of ASC transplantation on liver histology. (A) Hematoxylin–eosin stained liver sections from healthy rats showing
normal morphology; (B) liver sections from rats with acetaminophen intoxication and treated with vehicle showing lobular necrosis
and ballooning degeneration; (C) liver sections from animals transplanted with ASCs showing the absence of necroinflammation and
mitotic hepatocytes (arrows). (D) Indirect immunofluorescence on frozen liver sections from the group transplanted with ASCs
showing the presence of two GFP+ cells, one with a typical fibroblast-like phenotype (right of the panel), one with a round
epithelial-like phenotype (left). (E) Immunohistochemistry with a monoclonal antibody against human vimentin, a typical
mesenchymal marker, was positive in liver sections from transplanted rats; (F) immunohistochemistry for human CK-18 revealed
the presence of only rare ASCs undergoing differentiation. [Magnification: 20× (A,B,C); magnification 40× (D,E,F)].
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we treated in vitro these cells with 2 mM acetaminophen;
HPLC revealed undetectable NAPQI levels in cell medium at
any time point (data not shown), thus indicating the absence
of acetaminophen conversion by ASCs.Discussion
In the current study, we explored the effect of ASC
transplantation in rats with acetaminophen-induced liver
injury. Acetaminophen intoxication is a leading cause of ALF
in industrialized countries and the mortality is currently high
(Lee and Stravitz, 2011). The shortage of grafts for OLT
determines the need of novel therapies for ALF. There is
evidence that the transplantation of hepatocyte-like cells
derived from adult stem cell of various origin may represent
an effective strategy for the treatment of acute or chronic
liver diseases (Soltys et al., 2010). However, in our opinion
the use of undifferentiated ASCs is ideal in critical acute
conditions as in ALF because of their ready availability and
unrestricted potential to propagate. In fact, ASCs are
superior to bone marrow MSCs (BM-MSCs) and umbilical-
MSCs in terms of colony frequency and show also higher
proliferation capacity as compared to BM-MSCs (Kern et al.,
2006). The need for long-time period of culture makes the
use of hepatocyte-like cells unreliable for the management
of ALF. Furthermore, there is evidence that the transplan-
tation of undifferentiated MSCs is more effective thanthe transplantation of hepatocyte-like cells in rats with
CCl4-induced liver failure because of greater resistance to
oxidative stress (Kuo et al., 2008).
In this study, ASC transplantation was able to counteract
the appearance of coagulopathy and encephalopathy, which
are the two main clinical features of ALF (Lee and Stravitz,
2011). Transplanted animals had levels of transaminases,
INR and ammonia comparable to those of healthy control
rats and did not displayed brain edema (data not shown).
Consistently with clinical findings, we evidenced lobular
necrosis and inflammation in vehicle-treated animals,
whereas transplanted animals presented only mild injury.
With respect to the phenotype of ASCs in the host liver,
immunostaining with human monoclonal antibodies sug-
gested that ASCs exert their therapeutic role by maintaining
their fibroblast-like phenotype almost at this early time
point. Nonetheless, in few sections ASCs presented an
epithelial morphology and expressed epithelial markers as
CK-18; thus, it is not possible to exclude that in a longer
period of observation ASCs can undergo hepatogenic differ-
entiation although, in previous experiments with four weeks
of administration of BM-MSCs in CCl4-treated mice, only a
small percentage of MSCs underwent hepatocyte-like differ-
entiation (Sato et al., 2005). The presence of mitotic nuclei
in liver sections of transplanted animals and the increase of
cyclin D1 and PCNA suggest a trophic activity of ASCs which is
in agreement with previous data in mice treated with CCl4
and transplanted with ASCs (Banas et al., 2008). Trophic
activity and immunomodulation are considered key features
Figure 3 Effects of ASC transplantation on liver oxidative stress. (A–D) Rats intoxicated with acetaminophen displayed a marked
increase in hepatic levels of isoprostanes, 8-hydroxyguanosine (8-OHG) and nitrites/nitrates as compared with control healthy
animals and decreased GSH levels, indicating significant oxidative–nitrosative stress and impaired antioxidant defense; ASC
transplantation exerted potent antioxidant effects restoring isoprostanes, 8-OHG, nitrites/nitrates and GSH to the levels of control
group. (E) Representative Western blot and densitometric analysis showing that acetaminophen intoxication induced JNK
phosphorylation whereas the levels of total JNK were not significantly modified. In rats transplanted with ASCs, p-JNK expression
was restored to the levels observed in the control group. *P b 0.05 vs vehicle; **P b 0.05 vs APAP + vehicle.
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strated in chronic models of liver injury (Sato et al., 2005).
Regarding themolecular basis underlying the effects of ASC
transplantation, we demonstrated that these cells markedly
reduce oxidative stress in the liver of animals with acetamin-
ophen overdose. Oxidative stress plays a pivot role in
acetaminophen hepatotoxicity (Knight et al., 2002; James et
al., 2003; Cover et al., 2005). Here, we show that rats
transplanted with ASCs did not display increased levels of
isoprostanes, the most sensitive in vivo marker of oxidative
stress (Basu, 2008), neither of 8-OHG, a marker of DNAdamage, indicating that ASCs protected the rats from
acetaminophen-induced oxidative stress. Consistently, ASC
transplantation decreased nitrite/nitrates, which are markers
of nitrosative stress, to the levels observed in healthy
controls. This appears relevant because nitrogen radicals,
particular peroxynitrite, exert a role in acetaminophen
toxicity especially through DNA fragmentation (Das et al.,
2010). Interestingly, ASCs transplantation was able to inhibit
JNK activation. JNK signaling regulates the onset of hepato-
cyte death both in human and murine paracetamol hepato-
toxicity (Gunawan et al., 2006; Henderson et al., 2007; Ghosh
Figure 4 Effects of ASC transplantation on liver inflammatory cytokines. (A–D) Gene expression of TNF-α, MCP-1, IL-1β and ICAM-1
was induced by acetaminophen intoxication. In agreement with histological findings, ASC transplantation decreased the gene
expression of inflammatory cytokines to the levels observed in healthy controls. *P b 0.05 vs vehicle; **P b 0.05 vs APAP + vehicle.
Figure 5 Effects of ASC transplantation on liver regeneration. (A–C) Representative Western blot and densitometric analysis
showing a marked increase of liver cyclin D1 and PCNA in animals transplanted with ASCs as compared with rats treated with vehicle.
*P b 0.05 vs vehicle; **P b 0.05 vs APAP + vehicle.
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or anti-Fas antibody mediated hepatic injury (Gunawan et al.,
2006) suggesting specificity for the role of JNK in acetamin-
ophen hepatotoxicity.
In conclusion, in this study we demonstrated for the
first time that ASC transplantation is effective in treating
acetaminophen-induced liver injury. ASCs engraft in the
injured liver where they enhance hepatocyte regeneration
and inhibit stress and inflammatory signaling. Further animal
studies are needed to elucidate the complex molecular
events underlying ASC hepatoprotective effects. In our
opinion, these findings may provide a rationale for the
use of ASCs in the clinical management of patients with
acetaminophen intoxication.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.07.003.
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